Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS2R46 | P59540 | 4/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.34 |
| ▸ | MET | P08581 | 2/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | STAT3 | P40763 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504653 | 1.00 | TAS2R46 (0.38) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL17627758 | 1.00 | TAS2R46 (0.38) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL585278 | 1.00 | TAS2R46 (0.38) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL1153227 | 1.00 | TAS2R46 (0.38) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL8973506 | 0.95 | TAS2R46 (0.35) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL21004881 | 0.88 | TAS2R46 (0.32) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL21004882 | 0.88 | TAS2R46 (0.32) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL16236106 | 0.83 | TAS2R46 (0.35) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL16236105 | 0.83 | TAS2R46 (0.35) | TAS2R46MEN1KMT2ARECQLTDP1 | |
| SCHEMBL2575638 | 0.82 | LMNA (0.35) | TAS2R46MEN1KMT2ARECQLTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 695 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | claimed |
| US-20250302728-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2025-10-02 | — | — | US | claimed |
| EP-4526411-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | claimed |
| US-20250051370-A1 | SILICONE COMPOUNDS | PROCTER & GAMBLE (US) | 2025-02-13 | — | — | US | claimed |
| CN-119403907-A | Fragrance composition and product for delivering positive emotion | 西姆莱斯有限公司 | 2025-02-07 | — | — | CN | claimed |
| US-12187978-B2 | Use of (3-acetoxy-2,2-dimethyl-propyl) acetate in combination with (3-hydroxy-2,2-dimethyl-propyl) acetate as an aroma chemical | BASF SE (DE) | 2025-01-07 | — | — | US | claimed |
| WO-2023224604-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| WO-2023222753-A1 | FRAGRANCE COMPOSITIONS AND PRODUCTS CONVEYING A POSITIVE MOOD | SYMRISE AG (DE) | 2023-11-23 | — | — | WO | claimed |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | FIRMENICH SA (CH) | 2023-07-27 | — | — | US | claimed |
| US-20080096791-A1 | a mixture of perfumes selected form esters, aldehydes, alcohols, ketones or plant oils, used for promoting activated, pleasant moods through the inhalation | QUEST INTERNATIONAL SERVICES B.V. | 2008-04-24 | — | — | US | claimed |
| US-20080096790-A1 | a mixture of perfumes selected form esters, aldehydes, alcohols, ketones or plant oils, used for promoting activated, pleasant moods through the inhalation | QUEST INTERNATIONAL SERVICES B.V. | 2008-04-24 | — | — | US | claimed |
| EP-1869150-A1 | PERFUME COMPOSITIONS | Quest International Services B.V. (NL) | 2007-12-26 | — | — | EP | claimed |
| US-20070287659-A1 | Perfume Compositions | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2007-12-13 | — | — | US | claimed |
| EP-1737937-A2 | PERFUME COMPOSITIONS | Quest International Services B.V. (NL) | 2007-01-03 | — | — | EP | claimed |
| WO-2006109078-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2006-10-19 | — | — | WO | claimed |
| WO-2005103214-A2 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2005-11-03 | — | — | WO | claimed |
| US-20050245407-A1 | Fragrance composition | KAO CORPORATION (JP) | 2005-11-03 | — | — | US | claimed |
| EP-1552814-A1 | FRAGRANCE COMPOSITION | Kao Corporation (JP) | 2005-07-13 | — | — | EP | claimed |
| WO-1998056337-A1 | MALODOR REDUCING COMPOSITION CONTAINING AMBER AND MUSK MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250051370-A1 | SILICONE COMPOUNDS | SMCHD1, SRI, SMS | TAS2R46 1153/4885MEN1 49/4885KMT2A 1800/4885 |
| US-12234253-B2 | Silicone compounds with a substituted amine group and a benefit agent moiety | SMS, SRM, AAAS | TAS2R46 1020/4885MEN1 31/4885KMT2A 396/4885 |
| US-20230233425-A1 | USE OF VOLATILE COMPOSITIONS TO LIMIT OR ELIMINATE THE PERCEPTION OF MALODOR | TAS2R8, TRPA1, TAS2R10 | TAS2R46 54/4885MEN1 3715/4885KMT2A 4388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.